Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 229,664 | 252,657 | 276,251 | 299,998 | 320,211 |
| Receivables | 675 | 796 | 970 | N/A | N/A |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 273 |
| TOTAL | $234,444 | $256,753 | $282,086 | $303,817 | $322,515 |
| Non-Current Assets | |||||
| PPE Net | 103 | 106 | 89 | 61 | 33 |
| Other Non-Current Assets | 40 | 323 | 323 | 0 | 115 |
| TOTAL | $143 | $429 | $412 | $61 | $148 |
| Total Assets | $234,587 | $257,182 | $282,498 | $303,878 | $322,663 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,510 | 2,843 | 622 | 3,556 | 697 |
| Accrued Expenses | 16,427 | 11,872 | 8,319 | 5,398 | 1,939 |
| Other current liabilities | 2,706 | 2,218 | 6,814 | 6,839 | 7,458 |
| TOTAL | $28,643 | $16,933 | $15,755 | $15,892 | $10,378 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $28,643 | $16,933 | $15,755 | $15,892 | $10,378 |
| Shareholders' Equity | |||||
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -234,499 | -192,247 | -154,192 | -124,521 | -61,166 |
| TOTAL | $205,944 | $240,249 | $266,743 | $287,986 | $312,285 |
| Total Liabilities And Equity | $234,587 | $257,182 | $282,498 | $303,878 | $322,663 |